Adenocarcinoma of the Bladder
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08885 | Aflibercept | 2 | Completed | 1 |
| DB11714 | Durvalumab | 2 | Completed | 1 |
| DB13007 | Enfortumab vedotin | 2 | Not Yet Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Not Yet Recruiting | 1 |
| DB00398 | Sorafenib | 2 | Terminated | 1 |
| DB11771 | Tremelimumab | 2 | Completed | 1 |